Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Inflammatory Bowel Diseases

  Free Subscription


14.10.2019

3 Aliment Pharmacol Ther
2 Clin Gastroenterol Hepatol
2 Dis Colon Rectum
4 Gastroenterology
10 Inflamm Bowel Dis


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. SANDBORN WJ, Panes J, Sands BE, Reinisch W, et al
    Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme.
    Aliment Pharmacol Ther. 2019 Oct 9. doi: 10.1111/apt.15514.
    PubMed     Text format     Abstract available

  2. SELINGER CP, Parkes GC, Bassi A, Limdi JK, et al
    Assessment of steroid use as a key performance indicator in inflammatory bowel disease-analysis of data from 2385 UK patients.
    Aliment Pharmacol Ther. 2019 Oct 8. doi: 10.1111/apt.15497.
    PubMed     Text format     Abstract available

  3. DOLINGER MT, Rolfes P, Phan BL, Dubinsky MC, et al
    Letter: tofacitinib use for biologic-refractory paediatric inflammatory bowel disease.
    Aliment Pharmacol Ther. 2019;50:966-967.
    PubMed     Text format    


    Clin Gastroenterol Hepatol

  4. FUNG BM, Ali AH, Tabibian JH
    Associations between drug exposure and outcomes in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Clin Gastroenterol Hepatol. 2019 Oct 5. pii: S1542-3565(19)31095.
    PubMed     Text format    

  5. BARNES EL, Lightner AL, Regueiro M
    Peri-operative and Post-operative Management of Patients with Crohn's Disease and Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2019 Oct 4. pii: S1542-3565(19)31091.
    PubMed     Text format     Abstract available


    Dis Colon Rectum

  6. RYAN JM, Rogers AC, O'Toole A, Burke JP, et al
    Meta-analysis of Histological Margin Positivity in the Prediction of Recurrence After Crohn's Resection.
    Dis Colon Rectum. 2019;62:882-892.
    PubMed     Text format     Abstract available

  7. BERTUCCI ZOCCALI M, Hyman NH, Skowron KB, Rubin M, et al
    Exposure to Anti-tumor Necrosis Factor Medications Increases the Incidence of Pouchitis After Restorative Proctocolectomy in Patients With Ulcerative Colitis.
    Dis Colon Rectum. 2019;62:1344-1351.
    PubMed     Text format     Abstract available


    Gastroenterology

  8. CHEN JCY, Halawi H, Loftus CG
    New Ascites and Omental Thickening in Ulcerative Colitis.
    Gastroenterology. 2019 Jun 14. pii: S0016-5085(19)41014.
    PubMed     Text format    

  9. GONCZI L, Bessissow T, Lakatos P
    Ver(s)ifying the Efficacy of Vedolizumab Therapy on Mucosal Healing in Patients With Crohn's Disease.
    Gastroenterology. 2019;157:925-927.
    PubMed     Text format    

  10. PAPAMICHAEL K, Cheifetz AS
    Is It Prime Time for Proactive Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease?
    Gastroenterology. 2019;157:922-924.
    PubMed     Text format    

  11. COX SR, Lindsay JO, Fromentin S, Stagg AJ, et al
    Effects of Low-FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial.
    Gastroenterology. 2019 Sep 27. pii: S0016-5085(19)41366.
    PubMed     Text format     Abstract available


    Inflamm Bowel Dis

  12. KANE S
    Leter to the Editor.
    Inflamm Bowel Dis. 2019;25:e52.
    PubMed     Text format    

  13. CHETCUTI ZAMMIT S, McAlindon ME, Hale MF, Sanders DS, et al
    Small Bowel Ulcers on Capsule Endoscopy and Their Significance.
    Inflamm Bowel Dis. 2019;25:e55.
    PubMed     Text format    

  14. SZYMCZAK-TOMCZAK A, Krela-Kazmierczak I, Kaczmarek-Rys M, Hryhorowicz S, et al
    Does Only Sex Matter? Complexity of the Association Between Vdr Gene BsmI Single Nucleotide Polymorphism and Immune Response in IBD.
    Inflamm Bowel Dis. 2019;25:e56-e57.
    PubMed     Text format    

  15. JUN S
    Ethnicity May Be Important for Studying the Role of the Microbiome and Vitamin D Receptor in IBD.
    Inflamm Bowel Dis. 2019;25:e54.
    PubMed     Text format    

  16. SHMIDT E, Dulai PS
    Reply to the Letter to the Editor of Dr. Pauwels et al.
    Inflamm Bowel Dis. 2019;25:e58.
    PubMed     Text format    

  17. KAYAL M, Plietz M, Rizvi A, Radcliffe M, et al
    Inflammatory Pouch Conditions Are Common After Ileal Pouch Anal Anastomosis in Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2019 Oct 6. pii: 5581903. doi: 10.1093.
    PubMed     Text format     Abstract available

  18. NARDONE OM, Shivaji UN, Ferruzza V, Ghosh S, et al
    Soluble Blood Markers of Mucosal Healing in Inflammatory Bowel Disease: The Future of Noninvasive Monitoring.
    Inflamm Bowel Dis. 2019 Oct 6. pii: 5581902. doi: 10.1093.
    PubMed     Text format     Abstract available

  19. DAY AS
    Re: Parental Education May Differentially Modulate Pediatric Inflammatory Bowel Disease Phenotype Risk.
    Inflamm Bowel Dis. 2019 Oct 6. pii: 5581964. doi: 10.1093.
    PubMed     Text format    

  20. SCHOFIELD JB, Haboubi N
    Histopathological Mimics of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Oct 10. pii: 5584939. doi: 10.1093.
    PubMed     Text format     Abstract available

  21. KRISHNA M, Salako A, Fofanova T, Kellermayer R, et al
    Parental Education May Differentially Impact Pediatric Inflammatory Bowel Disease Phenotype Risk.
    Inflamm Bowel Dis. 2019 Oct 6. pii: 5581966. doi: 10.1093.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: